Procyrion. Aortix™ System Clinical Report - First in Man Experience in a High-Risk Percutaneous Coronary Intervention (HR-PCI) [n=6 patients]. PVR007_0. 2018.
Liu P. Cardiorenal Syndrome in HF: A Cardiologist’s Perspective. Canadian J Cardiology. 2008. 24:25B–29B. External Link
Benjamin et al. Heart Disease and Stroke Statistics - 2017 Update: A Report From the American Heart Association. Circulation. 2017. External Link
Lloyd-Jones et al. Lifetime Risk for Developing Congestive Heart Failure: The Framingham Heart Study. Circulation. 2002. 106:3068-72. External Link
Cook et al. The Annual Global Economic Burden of Heart Failure. Int J Cardiol. 2014 Feb 15. 171(3):368-76. External Link
Heywood et al. High Prevalence of Renal Dysfunction and Its Impact on Outcome in 118,465 Patients Hospitalized With Acute Decompensated Heart Failure: a Report From the ADHERE Database. Journal of Cardiac Failure. 2007. 13(6):422-30. External Link
Adams et al. Characteristics and Outcomes of Patients Hospitalized for Heart Failure in the United States: Rationale, Design, and Preliminary Observations From the First 100,000 Cases in the Acute Decompensated Heart Failure National Registry (ADHERE). American Heart Journal. 2005. 149:209-16. External Link
Based on ICD-10 codes for acute heart failure in National Inpatient Survey of data through 2017.
The Aortix™ device is currently in the research and development phase and is not available for sale in any country. Caution: Investigational Device. Limited by Federal Law to Investigational Use.